Aprea Therapeutics
APRE
$5.27
Share price
-3.48%
Change (1 day)
37.24%
Change (1 year)
Categories
Aprea Therapeutics (APRE) - P/B ratio
P/B ratio as of May 2024 : 1.79
According to Aprea Therapeutics's latest financial reports the company has a price-to-book ratio of 1.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aprea Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.04 | 51.43% |
| 2022-12-31 | 0.6841 | -45.03% |
| 2021-12-31 | 1.24 | -7.61% |
| 2020-12-31 | 1.35 | -82.63% |
| 2019-12-31 | 7.75 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Amedisys AMED | 2.72 | 51.65% | 🇺🇸 USA |
 Healthcare Services Group HCSG | 1.82 | 1.58% | 🇺🇸 USA |